Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Genomic Medicine, |
RCV002268730 | SCV002550311 | uncertain significance | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002434615 | SCV002746708 | uncertain significance | Hereditary cancer-predisposing syndrome | 2017-10-23 | criteria provided, single submitter | clinical testing | The p.I943T variant (also known as c.2828T>C), located in coding exon 10 of the BRCA2 gene, results from a T to C substitution at nucleotide position 2828. The isoleucine at codon 943 is replaced by threonine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
University of Washington Department of Laboratory Medicine, |
RCV002434615 | SCV003850167 | likely benign | Hereditary cancer-predisposing syndrome | 2023-03-23 | criteria provided, single submitter | curation | Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673). |